Everolimus-eluting stents or bypass surgery for left main coronary artery disease.

<h4>Background</h4> <p>Patients with obstructive left main coronary artery disease are usually treated with coronary-artery bypass grafting (CABG). Randomized trials have suggested that drug-eluting stents may be an acceptable alternative to CABG in selected patients with left mai...

Full description

Bibliographic Details
Main Authors:	Stone, GW, Sabik, JF, Serruys, PW, Simonton, CA, Généreux, P, Puskas, J, Kandzari, DE, Morice, MC, Lembo, N, Brown, WM, Taggart, DP, Banning, A, Merkely, B, Horkay, F, Boonstra, PW, van Boven, AJ, Ungi, I, Bogáts, G, Mansour, S, Noiseux, N, Sabaté, M, Pomar, J, Hickey, M, Gershlick, A, Buszman, P, Bochenek, A, Schampaert, E, Pagé, P, Dressler, O, Kosmidou, I, Mehran, R, Pocock, SJ, Kappetein, AP
Format:	Journal article
Language:	English
Published:	Massachusetts Medical Society 2016

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.

Similar Items